GLP-1 receptor agonists (GLP-1RAs) like liraglutide and semaglutide, as well as the dual GLP-1 and gastric inhibitory polypeptide (GIP) agonist tirzerpatide are a class of medications that were historically designed to treat type 2 diabetes
Accurate dilution is absolutely paramount to ensure you're administering the correct dosage in your research
Under Canada's established generic pricing framework negotiated through the pan-Canadian Pharmaceutical Alliance (pCPA) the first generic to market typically enters at 7585% of the brand price
All data are available in the main text or in the supplementary materials upon request, access can be obtained by contacting the corresponding author via email
Updated 07/17/2020 19:40hs INSTAGRAM LIVE Q&A Selected References Cai, J., Chen, Y., Seth, S., Furukawa, S., Compans, R